<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">23421</article-id><article-id pub-id-type="doi">10.7554/eLife.23421</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Defining the biological basis of radiomic phenotypes in lung cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-37670"><name><surname>Grossmann</surname><given-names>Patrick</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4918-6902</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77217"><name><surname>Stringfield</surname><given-names>Olya</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87599"><name><surname>El-Hachem</surname><given-names>Nehme</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56690"><name><surname>Bui</surname><given-names>Marilyn M</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-91447"><name><surname>Rios Velazquez</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77213"><name><surname>Parmar</surname><given-names>Chintan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77214"><name><surname>Leijenaar</surname><given-names>Ralph TH</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77215"><name><surname>Haibe-Kains</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-77216"><name><surname>Lambin</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29857"><name><surname>Gillies</surname><given-names>Robert</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8888-7747</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-74532"><name><surname>Aerts</surname><given-names>Hugo JWL</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2122-2003</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Radiation Oncology</institution>, <institution>Dana-Farber Cancer Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Cancer Imaging and Metabolism</institution>, <institution>H. Lee Moffitt Cancer Center and Research Institute</institution>, <addr-line><named-content content-type="city">Tampa</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Integrative systems biology</institution>, <institution>Institut de recherches cliniques de Montreal</institution>, <addr-line><named-content content-type="city">Montreal</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution content-type="dept">Department of Anatomic Pathology</institution>, <institution>H. Lee Moffitt Cancer Center and Research Institute</institution>, <addr-line><named-content content-type="city">Tampa</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Radiation Oncology (MAASTRO)</institution>, <institution>Research Institute GROW, Maastricht University</institution>, <addr-line><named-content content-type="city">Maastricht</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff6"><institution content-type="dept">Princess Margaret Cancer Centre</institution>, <institution>University Health Network</institution>, <addr-line><named-content content-type="city">Toronto</named-content></addr-line>, <country>Canada</country></aff><aff id="aff7"><institution content-type="dept">Department of Cancer Imaging and Metabolism</institution>, <institution>H. Lee Moffitt Cancer Center and Research Institute</institution>, <addr-line><named-content content-type="city">Tampa</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-11563"><name><surname>Bivona</surname><given-names>Trever</given-names></name><role>Reviewing editor</role><aff><institution>University of California, San Francisco</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hugo_aerts@dfci.harvard.edu</email> (HA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>07</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e23421</elocation-id><history><date date-type="received"><day>20</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>07</month><year>2017</year></date></history><permissions><copyright-statement>Â© 2017, Grossmann et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Grossmann et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-23421-v1.pdf"/><abstract><p>Medical imaging can visualize characteristics of human cancer noninvasively. Radiomics is an emerging field that translates these medical images into quantitative data to enable phenotypic profiling of tumors. While radiomics has been associated with several clinical endpoints, the complex relationships of radiomics, clinical factors, and tumor biology are largely unknown. To this end, we analyzed two independent cohorts of respectively 262 North American and 89 European patients with lung cancer, and consistently identified previously undescribed associations between radiomic imaging features, molecular pathways, and clinical factors. In particular, we found a relationship between imaging features, immune response, inflammation, and survival, which was further validated by immunohistochemical staining. Moreover, a number of imaging features showed predictive value for specific pathways; for example, intra-tumor heterogeneity features predicted activity of RNA polymerase transcription (AUC=0.62, <italic>p</italic>=0.03) and intensity dispersion was predictive of the autodegration pathway of a ubiquitin ligase (AUC = 0.69, <italic>p &lt; </italic>10<sup>-4</sup>). Finally, we observed that prognostic biomarkers performed highest when combining radiomic, genetic, and clinical information (CI=0.73, <italic>p</italic>&lt;10<sup>-9</sup>) indicating complementary value of these data. In conclusion, we demonstrate that radiomic approaches permit noninvasive assessment of both molecular and clinical characteristics of tumors, and therefore have the potential to advance clinical decision-making by systematically analyzing standard of care medical images.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH-USA U24CA194354</award-id><principal-award-recipient><name><surname>Aerts</surname><given-names>Hugo JWL</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH-USA U01CA190234</award-id><principal-award-recipient><name><surname>Aerts</surname><given-names>Hugo JWL</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH/NCI U01CA143062</award-id><principal-award-recipient><name><surname>Gillies</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH/NCI P50CA119997</award-id><principal-award-recipient><name><surname>Gillies</surname><given-names>Robert</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>QuIC-ConCePT</institution></institution-wrap></funding-source><award-id>IMI JU Grant No. 115151</award-id><principal-award-recipient><name><surname>Lambin</surname><given-names>Philippe</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Technologiestichting STW</institution></institution-wrap></funding-source><award-id>10696 DuCA</award-id><principal-award-recipient><name><surname>Lambin</surname><given-names>Philippe</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Dutch Cancer Society</institution></institution-wrap></funding-source><award-id>KWF UM 2009-4454</award-id><principal-award-recipient><name><surname>Lambin</surname><given-names>Philippe</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Dutch Cancer Society</institution></institution-wrap></funding-source><award-id>KWF MAC 2013-6425</award-id><principal-award-recipient><name><surname>Lambin</surname><given-names>Philippe</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Gattuso Slaight Personalized Cancer Medicine Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Haibe-Kains</surname><given-names>Benjamin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Robert Gillies, declares a collaboration with HealthMyne..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The University of South Florida institutional review board approved and waived the informed consent requirement (IRB # 16069) retrospective study of Dataset1; data were collected and handled in accordance with the Health Insurance Portability and Accountability Act. Informed consent for gene expression collection was written and oral. For acquisition of imaging and clinical data USF IRB approved protocol (108426) provided a waiver of informed consent for this retrospective study. Data collection and analysis of Dataset2 was carried out in accordance with Dutch law; the corresponding institutional review board approved the study. All patient data were anonymized and de-identified prior to the analyses.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="datasets"><title>Major datasets</title><p/><p>The following previously published datasets were used:</p><p><related-object content-type="generated-dataset" id="dataro1" source-id="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58661" source-id-type="uri"><collab>Aerts and Grossmann</collab>, <year>2014</year><x>,</x> <source>89 NSCLC patients with gene expression profiles and matching CT imaging data available at TCIA</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58661">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE58661</ext-link><x>,</x> <comment>GSE58661</comment></related-object></p></sec><supplementary-material><ext-link xlink:href="elife-23421-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>